BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

13868

543748

AARTIPHARM

img img img img
No Data Available

Aarti Pharmalabs performance

Today’s low

Today’s high

₹ 717.20 ₹ 730.00
₹ 721.55

52 week low

52 week high

₹ 557.05 ₹ 971.00
₹ 721.55

Open Price

₹ 724.00

Prev. Close

₹ 723.45

Volume (Shares)

143818.00

Total traded value

₹ 1037.71

Upper Circuit

₹ 868.10

Lower Circuit

₹ 578.80

info

Aarti Pharmalabs Share Price Update

As of the latest trading session, Aarti Pharmalabs share price is currently at ₹ 721.55, which is down by ₹ -1.90 from its previous closing. Today, the stock has fluctuated between ₹ 717.20 and ₹ 730.00. Over the past year, Aarti Pharmalabs has achieved a return of 11.96 %. In the last month alone, the return has been -14.49 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Aarti Pharmalabs fundamentals


  • Market cap (Cr)

    6,540.70

  • P/E Ratio (TTM)

    26.77

  • Beta

    1.06

  • Book Value / share

    210.00

  • Return on equity

    14.85%

  • EPS (TTM)

    26.97

  • Dividend yield

    0.69%

  • Net profit/quarter (Cr)

    30.93

info icon alternate text
  • Market cap (Cr)

    6,545.20

  • P/E Ratio (TTM)

    26.77

  • Beta

    0.96

  • Book Value / share

    210.00

  • Return on equity

    14.85%

  • EPS (TTM)

    26.97

  • Dividend yield

    0.69%

  • Net profit/quarter (Cr)

    30.93

info icon alternate text

Aarti Pharmalabs Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 417.29
Operating Expense 378.73
Net Profit 30.93
Net Profit Margin (%) 7.41
Earnings Per Share (EPS) 3.41
EBITDA 77.13
Effective Tax Rate (%) 25.82
Particulars JUN 2025 (Values in Cr)
Revenue 375.31
Operating Expense 309.73
Net Profit 51.22
Net Profit Margin (%) 13.64
Earnings Per Share (EPS) 5.65
EBITDA 96.72
Effective Tax Rate (%) 23.74
Particulars MAR 2025 (Values in Cr)
Revenue 529.62
Operating Expense 413.62
Net Profit 88.85
Net Profit Margin (%) 16.77
Earnings Per Share (EPS) 9.80
EBITDA 140.62
Effective Tax Rate (%) 21.72
Particulars DEC 2024 (Values in Cr)
Revenue 470.95
Operating Expense 386.70
Net Profit 73.52
Net Profit Margin (%) 15.61
Earnings Per Share (EPS) 8.11
EBITDA 126.92
Effective Tax Rate (%) 23.55
Particulars SEP 2024 (Values in Cr)
Revenue 377.29
Operating Expense 316.80
Net Profit 47.84
Net Profit Margin (%) 12.67
Earnings Per Share (EPS) 5.28
EBITDA 87.71
Effective Tax Rate (%) 24.59
Particulars MAR 2025 (Values in Cr)
Revenue 1771.35
Operating Expense 1449.50
Net Profit 257.35
Net Profit Margin (%) 14.52
Earnings Per Share (EPS) 28.39
EBITDA 441.03
Effective Tax Rate (%) 23.48
Particulars MAR 2024 (Values in Cr)
Revenue 1502.13
Operating Expense 1238.62
Net Profit 200.65
Net Profit Margin (%) 13.35
Earnings Per Share (EPS) 22.14
EBITDA 357.15
Effective Tax Rate (%) 26.90
Particulars MAR 2023 (Values in Cr)
Revenue 1511.25
Operating Expense 1279.17
Net Profit 171.73
Net Profit Margin (%) 11.36
Earnings Per Share (EPS) 18.95
EBITDA 309.62
Effective Tax Rate (%) 26.40
Particulars MAR 2022 (Values in Cr)
Revenue 941.02
Operating Expense 809.80
Net Profit 106.73
Net Profit Margin (%) 11.34
Earnings Per Share (EPS) 11.78
EBITDA 182.29
Effective Tax Rate (%) 20.18
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.18
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 219.55
ROE % 14.54
ROCE % 17.35
Total Debt to Total Equity 0.19
EBITDA Margin 22.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 193.88
ROE % 13.08
ROCE % 16.60
Total Debt to Total Equity 0.15
EBITDA Margin 21.10
Particulars MAR 2023 (Values in Cr)
Book Value / Share 171.97
ROE % 13.14
ROCE % 16.07
Total Debt to Total Equity 0.19
EBITDA Margin 17.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share 53646.60
ROE % 17.63
ROCE % 19.37
Total Debt to Total Equity 0.25
EBITDA Margin 17.46
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.12
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 203.44
ROE % 14.85
ROCE % 17.33
Total Debt to Total Equity 0.20
EBITDA Margin 24.90
Particulars MAR 2024 (Values in Cr)
Book Value / Share 178.92
ROE % 13.11
ROCE % 16.40
Total Debt to Total Equity 0.16
EBITDA Margin 23.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 158.74
ROE % 12.61
ROCE % 15.56
Total Debt to Total Equity 0.20
EBITDA Margin 20.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 49558.52
ROE % 16.62
ROCE % 18.00
Total Debt to Total Equity 0.25
EBITDA Margin 19.37
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.07
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 8.64
Total Assets 2906.40
Total Liabilities 2906.40
Total Equity 1989.90
Share Outstanding 90634624
Price to Book Ratio 3.68
Return on Assets (%) 9.37
Return on Capital (%) 11.42
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 24.06
Total Assets 2582.10
Total Liabilities 2582.10
Total Equity 1757.03
Share Outstanding 90626008
Price to Book Ratio 2.43
Return on Assets (%) 8.40
Return on Capital (%) 10.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.19
Total Assets 2244.02
Total Liabilities 2244.02
Total Equity 1558.48
Share Outstanding 90626008
Price to Book Ratio 1.73
Return on Assets (%) 8.62
Return on Capital (%) 10.91
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 83.27
Total Assets 2039.89
Total Liabilities 2039.89
Total Equity 1386.47
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) 5.99
Return on Capital (%) 7.09
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 0.25
Total Liabilities 0.25
Total Equity 0.22
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) -1.83
Return on Capital (%) -1.87
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.52
Total Assets 2723.60
Total Liabilities 2723.60
Total Equity 1843.87
Share Outstanding 90634624
Price to Book Ratio 3.68
Return on Assets (%) 9.44
Return on Capital (%) 11.5
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.42
Total Assets 2296.91
Total Liabilities 2296.91
Total Equity 1621.45
Share Outstanding 90626008
Price to Book Ratio 2.43
Return on Assets (%) 8.73
Return on Capital (%) 10.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 1976.36
Total Liabilities 1976.36
Total Equity 1438.57
Share Outstanding 90626008
Price to Book Ratio 1.73
Return on Assets (%) 8.68
Return on Capital (%) 10.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 56.49
Total Assets 1826.83
Total Liabilities 1826.83
Total Equity 1284.27
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) 5.84
Return on Capital (%) 6.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 0.25
Total Liabilities 0.25
Total Equity 0.22
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) -1.83
Return on Capital (%) -2.03
Particulars MAR 2025 (Values in Cr)
Net Income 360.68
Cash from Operations 396.08
Cash from Investing -413.89
Cash from Financing 65.43
Net change in Cash -16.90
Free Cash Flow 798.12
Particulars MAR 2024 (Values in Cr)
Net Income 300.49
Cash from Operations 273.29
Cash from Investing -214.56
Cash from Financing 9.72
Net change in Cash 11.51
Free Cash Flow 428.89
Particulars MAR 2023 (Values in Cr)
Net Income 260.77
Cash from Operations 312.49
Cash from Investing -157.80
Cash from Financing -163.46
Net change in Cash -71.15
Free Cash Flow 414.62
Particulars MAR 2022 (Values in Cr)
Net Income 155.38
Cash from Operations -22.57
Cash from Investing -138.73
Cash from Financing 260.38
Net change in Cash 77.94
Free Cash Flow 118.57
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2025 (Values in Cr)
Net Income 336.34
Cash from Operations 398.50
Cash from Investing -419.80
Cash from Financing 78.63
Net change in Cash -1.16
Free Cash Flow 789.98
Particulars MAR 2024 (Values in Cr)
Net Income 274.51
Cash from Operations 230.68
Cash from Investing -184.39
Cash from Financing 4.39
Net change in Cash 3.69
Free Cash Flow 376.64
Particulars MAR 2023 (Values in Cr)
Net Income 233.35
Cash from Operations 272.61
Cash from Investing -115.55
Cash from Financing -156.52
Net change in Cash -56.19
Free Cash Flow 371.53
Particulars MAR 2022 (Values in Cr)
Net Income 133.72
Cash from Operations -49.84
Cash from Investing -133.53
Cash from Financing 254.62
Net change in Cash 56.24
Free Cash Flow 86.18
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.75 13.60 1.44 212.66 27.02 / 68.00
BLISS GVS PHARMA LTD 171.05 16.49 1.59 1808.38 105.05 / 190.65
CIPLA LTD 1520.55 22.57 3.73 122825.65 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 269.00 7.07 2.02 791.69 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 27.75 22.56 3.86 212.66 27.02 / 68.00
AMRUTAJAN HEALTH LTD 655.35 33.42 5.53 1894.66 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9211.50 99.62 28.82 23028.75 6301.00 / 10653.05
BLISS GVS PHARMA LTD 171.05 23.08 1.63 1808.38 105.05 / 190.65

Aarti Pharmalabs shareholding pattern

Holding

42.14%
42.88%
8.01%
6.95%
0.01%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Aarti Pharmalabs Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
721.55 -0.26 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 713.40
  • 26 Days 740.60
  • 10 Days 712.30
  • 50 Days 776.00
  • 12 Days 714.50
  • 100 Days 804.70
  • 20 Days 729.00
  • 200 Days 791.50
717.68 PIVOT

First Support

709.52

First Resistance

731.62

Second Support

695.58

Second Resistance

739.78

Third Support

687.42

Third Resistance

753.72

RSI

43.26

ADX

53.26

MACD

-26.06

Williams % R

-24.20

Commodity Channel Index (CCI)

16.49

Date

2025-12-05

Week

98643.00

Same Day

75787.00

Month

152440.00

1 Year

1.06

3 Year

0.92

Over 1 Month

-14.49%

down

Over 1 Year

11.96%

down

Over 3 Months

-18.25%

down

Over 3 Years

35.77%

down

Over 6 Months

-22.01%

down

Over 5 Years

0.00%

down

Aarti Pharmalabs Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
15 Sep 2025 2.5 Final 15 Sep 2025 Equity shares
14 Feb 2025 2.5 Interim 14 Feb 2025 Equity shares
31 Jul 2024 1.0 Final 31 Jul 2024 Equity shares
16 Feb 2024 2.0 Interim 19 Feb 2024 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
15 Sep 2025 2.5 Final 15 Sep 2025 Equity shares
14 Feb 2025 2.5 Interim 14 Feb 2025 Equity shares
31 Jul 2024 1.0 Final 31 Jul 2024 Equity shares
16 Feb 2024 2.0 Interim 19 Feb 2024 Equity shares

Aarti Pharmalabs Share Price

Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019. The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022. Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc.

In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.

In 2021-22, the Pharmaceutical Division was demerged from Aarti Industries Limited into its wholly owned subsidiary, Aarti Pharmalabs Limited, via Scheme of Arrangement for Demerger, thus making it effective on October 17, 2022 and operational from July 1, 2021. Thereafter, Company commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.

The R&D centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company commenced operations for its semi-commercial block at the USFDA intermediate manufacturing site in Vapi in FY24. The Xanthine capacity enhanced to 5000 TPA in 2024.

Parent organization Indian Private
NSE symbol AARTIPHARM
Founded 2019
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Aarti Pharmalabs Ltd?

Answer Field

Aarti Pharmalabs Ltd share price is for NSE ₹ 721.55 & for BSE ₹ 721.55 as on Dec 05 2025 03:30 PM.

What is the Market Cap of Aarti Pharmalabs Ltd Share?

Answer Field

The market cap of Aarti Pharmalabs Ltd for NSE ₹ 6,539.74 & for BSE ₹ 6,539.74 as on Dec 05 2025 03:30 PM.

What is the 52 Week High and Low of Aarti Pharmalabs Ltd?

Answer Field

The 52 Week High and Low of Aarti Pharmalabs Ltd for NSE is ₹ 971.00 and ₹ 557.05 and for BSE is ₹ 971.50 and ₹ 550.25.

What is 1 year return for Aarti Pharmalabs Ltd?

Answer Field

The 1 year returns on the stock has been 11.96%.

What is the P/E Ratio of Aarti Pharmalabs Ltd Share?

Answer Field

As on Dec 05 2025 03:30 PM the price-to-earnings (PE) ratio for Aarti Pharmalabs Ltd share is 26.77.

What is the PB ratio of Aarti Pharmalabs Ltd Share?

Answer Field

As on Dec 05 2025 03:30 PM, the price-to-book (PB) ratio for Aarti Pharmalabs Ltd share is 210.00.

How to Buy Aarti Pharmalabs Ltd Share?

Answer Field

You can trade in Aarti Pharmalabs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aarti Pharmalabs Ltd Share on Bajaj Broking App?

Answer Field

To buy Aarti Pharmalabs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aarti Pharmalabs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59